2015 年 47 巻 5 号 p. 11-28
This paper examines the organizational capabilities in the pharmaceutical research and development. Based on interviews with major Japanese pharmaceutical companies and statistical analysis of published data, this study shows that the go or no−go decision−making capability and the protocol design capability are significant organizational capabilities that differ among companies and affect research and development performance.